Abstract 1879P
Background
Cancer affects many aspects of life and can have negative consequences such as reducedː health and quality of life and mental disorders. Cancer patients face most of the stressors associated with diagnosis and treatment. The aim of this study is investigating the effect of family support on the mental health of patients with breast Cancer.
Methods
This cross-sectional study examined 70 breast cancer patients who were referred within 6 months to Imam Khomeini and Shohadah Ha* Tir Hospitals for radiotherapy, chemotherapy or follow- up treatment. In terms of mental health, these patients were assessed using the criteria of hospital anxiety and depression and distress thermometer, and the level of family support using the McMaster Family Assessment Device and attachment style criteria. The psychiatric interview with the patients was conducted by the psychiatric resident and all questionnaires were completed by her in face-to-face interviews or video calls with the patient. Before the start of the study, all patients gave written informed consent. The Family Support Questionnaire contains 60 questions that identify the structural, professional, and interactive characteristics of the family. This questionnaire has 7 subscales.
Results
The mean (standard deviation) of the total score on the Family Support Questionnaire for the subjects studied was 15.7 (2.96) with a range of 9.87 to 21.06. the mean (standard deviation) of anxiety and depression scores were 9.68 (5.34) and 8.34 (4.41), respectively. the results show that increasing the score on anxiety and depression significantly increases family support and its sub-comparisons.
Conclusions
The study revealed that the mean scores of the depression and anxiety in breast cancer patients is more than normal limitation. The results showed that decreasing family support and its sub- comparisons (an increase in the score indicates an unhealthy situation) significantly increases anxiety and depression in these individuals.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Iran University of Medical Sciences.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05